InNexus Biotechnology (InNexus Biotechnology) FCF Margin % : 0.00% (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. InNexus Biotechnology's Free Cash Flow for the three months ended in Mar. 2011 was $-0.12 Mil. InNexus Biotechnology's Revenue for the three months ended in Mar. 2011 was $0.00 Mil. Therefore, InNexus Biotechnology's FCF Margin % for the quarter that ended in Mar. 2011 was 0.00%.

As of today, InNexus Biotechnology's current FCF Yield % is 0.00%.

The historical rank and industry rank for InNexus Biotechnology's FCF Margin % or its related term are showing as below:

IXSBF's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -137.43
* Ranked among companies with meaningful FCF Margin % only.

InNexus Biotechnology FCF Margin % Historical Data

The historical data trend for InNexus Biotechnology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology FCF Margin % Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

FCF Margin %

Get a 7-Day Free Trial

-5,939.02

-19,428.57

-946,200.00

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of InNexus Biotechnology's FCF Margin %

For the Biotechnology subindustry, InNexus Biotechnology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's FCF Margin % falls into.

InNexus Biotechnology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

InNexus Biotechnology's FCF Margin for the fiscal year that ended in Jun. 2010 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2010 )	/	Revenue (A: Jun. 2010 )
	=	-1.545	/	0
	=	%

InNexus Biotechnology's FCF Margin for the quarter that ended in Mar. 2011 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2011 )	/	Revenue (Q: Mar. 2011 )
	=	-0.118	/	0
	=	%

InNexus Biotechnology FCF Margin % Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines